eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2021
vol. 72
 
Share:
Share:
abstract:
Original paper

Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma

Arbil Acikalin
1
,
Emine Bagir
1
,
Semra Paydas
2

  1. Pathology Department, Medical Faculty, Cukurova University, Adana, Turkey
  2. Oncology Department, Medical Faculty, Cukurova University, Adana, Turkey
Pol J Pathol 2021; 72 (2): 140-147
Online publish date: 2021/09/30
View full text Get citation
 
PlumX metrics:
Merkel cell carcinoma (MCC) is a rare and lethal type of skin cancer characterized by frequent recurrences and metastases. In view of the lack of a proven treatment option for MCC, we immunochemically evaluated the presence of Merkel cell polyomavirus (MCPyV), PD-1, PD-L1, CD8, and EZH2 on slides prepared from tumor tissues of 13 patients with MCC, and examined their association with disease progression and overall survival. PD-1 was expressed on tumor infiltrating lymphocytes (TILs) in 92.3% of the patients. None of the tumor cells expressed PD-L1. CD8 levels were higher in MCPyV-positive tumors. Interestingly, higher CD8 levels correlated with better overall survival (p = 0.025), while higher EZH2 expression correlated with metastasis/recurrence (z = –1.396, p = 0.089). However, low EZH2 expression was associated with poor overall survival (χ2 = 3.745, Cramer V = 0.537, p = 0.086). These findings suggest that EZH2 plays a significant role in MCC and may be a promising therapeutic target.
keywords:

CD8, EZH2, Merkel cell carcinoma, PD-1, PD-L1

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.